Holbaek Sygehus — Clinical Trial Site

25 Registered trials

12 Currently recruiting

Organisation

Holbaek Sygehus

Location

Holbæk, Denmark

Identifier

ORG-100044239

Address

Smedelundsgade 60, 4300, Denmark

Departments

Cardiology
Department of Cardiology
Department of Emergency Medicine
Department of Intensive Care
Department of Internal Medicine
Department of medicine 1
Dept. of Internal Medicine
Dept. of Pediatrics
Forskningsenheden 44-4, rum 4
Hjertemedicinsk Forskningsenhed
Holbaek Sygehus
Holbæk Sygehus - Forskningsenheden, Medicinsk Afdeling
Internal Medicine
Medicine
Medicine 1, Clinical Research Unit, 44-4
Medicinsk Afdeling
N/A
NA

Clinical trials at this site (25)

Search interface

A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending

2023-509176-42-00 Obesity and T2D 11
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting

2023-509703-33-00 Septic Shock 6 2025-06-26
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio… Recruiting

2024-519525-38-00 Heart failure 5 2025-08-22
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
Brachial plexus nerve block for closed reduction of distal radius fracture Recruiting

2024-512191-35-00 Distal radius fracture in need of acute closed reductio 6 2024-12-10
DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p… Recruiting

2022-502500-75-00 Atrial fibrillation 6 2024-01-30
INVITED trial Recruiting

2022-500906-17-01 Type 1 diabetes 4 2023-03-21
Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting

2022-500143-21-01 Type 2 diabetes 6 2023-01-12
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended

2023-508055-40-00 Obesity 6 2025-02-18
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended

2023-506924-94-00 Cardiovascular disease 5 2023-02-28
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29
A trial to learn how well finerenone works and how safe it is in adult participants with non-diabetic chronic kidney disease Ended

2023-506897-11-00 Non-diabetic chronic kidney disease 5 2021-10-18
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Myocardinal infarction 5 2018-12-01